{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:44:21Z","timestamp":1790045061144,"version":"4.0.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015690","name":"Universitas Padjadjaran","doi-asserted-by":"publisher","award":["5317\/UN6.C\/PT.02\/2025"],"award-info":[{"award-number":["5317\/UN6.C\/PT.02\/2025"]}],"id":[{"id":"10.13039\/501100015690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Drug-resistant tuberculosis (DR-TB) poses a serious challenge in Indonesia, with treatment success rates of only 50%. The BPaLM\/BPaL regimen represents the latest therapeutic approach, offering shorter duration, minimal side effects, and treatment success rates of 84\u201390%. An operational research study conducted in Indonesia from July 2022 to March 2023 demonstrated a highly promising treatment success rate of 97.6% with the BPaLM\/BPaL regimen. This study aimed to evaluate the effectiveness of the BPaLM\/BPaL regimen through real-world implementation among individuals with DR-TB and identify key factors associated with successful treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study analyzed 170 DR-TB individuals treated with BPaLM\/BPaL regimens at Hasan Sadikin General Hospital, a tertiary hospital in West Java, Indonesia from January 2024 to January 2025. Data were collected from the Indonesian National DR-TB registers. A successful treatment outcome was defined as completion of treatment with bacteriological response and no evidence of treatment failure. Multivariate logistic regression was used to identify factors most associated with successful treatment outcomes and presented as adjusted odds ratios (aOR) with 95% confidence intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study achieved an 88.8% successful treatment rate with BPaLM\/BPaL regimens. Multivariate analysis revealed treatment with no missed dose events as the most important predictor for successful treatment outcome with aOR=6.42 (95%CI 1.44\u201328.45, p\u2009=\u20090.01), followed by nutritional status improvement during treatment with aOR=3.31 (95%CI 1.06\u201310.37, p\u2009=\u20090.03). A total of 132 patients (77.6%) experienced adverse effects, predominantly gastrointestinal symptoms (93.1%) and peripheral neuropathy (30.3%). Culture conversion occurred within 2 months in 95.2% of patients, with a median time to conversion of 111 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>No missed dose events and nutritional status improvement are key predictors of successful treatment outcome. These findings support the implementation of BPaLM\/BPaL regimens in Indonesia's national TB program, with emphasis on ensuring treatment adherence and nutritional status monitoring for optimal outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0345702","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:27:30Z","timestamp":1775064450000},"page":"e0345702","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Factors Predicting successful treatment outcome with novel BPaLM\/BPaL regimen in individuals with drug-resistant tuberculosis: Experience From Indonesia"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9027-2453","authenticated-orcid":true,"given":"Arto Yuwono","family":"Soeroto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3093-8409","authenticated-orcid":true,"given":"Aga","family":"Purwiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendarsyah","family":"Suryadinata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bachti","family":"Alisjahbana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3779-3414","authenticated-orcid":true,"given":"Afiatin","family":"Makmun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana Akhmad","family":"Supriatna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmy Hermiyanti","family":"Pranggono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6476-2034","authenticated-orcid":true,"given":"Bony Wiem","family":"Lestari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"pone.0345702.ref001","doi-asserted-by":"crossref","DOI":"10.54394\/CJQU6666","volume-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024"},{"key":"pone.0345702.ref002","unstructured":"Kementerian Kesehatan Republik Indonesia. Petunjuk teknis penatalaksanaan tuberkulosis resistan obat di Indonesia. 2024."},{"key":"pone.0345702.ref003","first-page":"1708","article-title":"The efficacy of bedaquiline versus kanamycin in multi-drug resistant tuberculosis: a systematic scoping review","volume":"26","author":"L Singh","year":"2021","journal-title":"Health SA"},{"issue":"2","key":"pone.0345702.ref004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246284","article-title":"Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: a retrospective cohort study","volume":"16","author":"AY Soeroto","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"pone.0345702.ref005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263304","article-title":"Factors associated with treatment outcome of MDR\/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia","volume":"17","author":"AY Soeroto","year":"2022","journal-title":"PLoS One"},{"issue":"7","key":"pone.0345702.ref006","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf344","article-title":"High rates of mortality during drug-resistant tuberculosis treatment among individuals with diabetes mellitus and low body mass index","volume":"12","author":"LD Veeken","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"pone.0345702.ref007","doi-asserted-by":"crossref","first-page":"100470","DOI":"10.1016\/j.jctube.2024.100470","article-title":"Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis","volume":"37","author":"TM Johnson","year":"2024","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"3","key":"pone.0345702.ref008","doi-asserted-by":"crossref","DOI":"10.52225\/narra.v3i3.402","article-title":"Efficacy of pretomanid-containing regiments for drug-resistant tuberculosis: a systematic review and meta-analysis of clinical trials","volume":"3","author":"AM Simanjuntak","year":"2023","journal-title":"Narra J"},{"issue":"10","key":"pone.0345702.ref009","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"F Conradie","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0345702.ref010","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa2119430","article-title":"Bedaquiline-pretomanid-linezolid regimens for drug-resistant tuberculosis","volume":"387","author":"F Conradie","year":"2022","journal-title":"N Engl J Med"},{"issue":"25","key":"pone.0345702.ref011","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1056\/NEJMoa2117166","article-title":"A 24-Week, all-oral regimen for rifampin-resistant tuberculosis","volume":"387","author":"B-T Nyang\u2019wa","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0345702.ref012","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5588\/ijtldopen.24.0524","article-title":"Treatment success rate and time to culture conversion under a prospective BPaL cohort study","volume":"2","author":"E Burhan","year":"2025","journal-title":"IJTLD Open"},{"issue":"1","key":"pone.0345702.ref013","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13756-024-01480-8","article-title":"Predictors of early and interim culture un-conversion in multidrug-resistant\/rifampicin-resistant tuberculosis: a retrospective multi-center cohort study in China","volume":"13","author":"Q Chen","year":"2024","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"pone.0345702.ref014","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/2251-6581-12-58","article-title":"Diabetes mellitus and tuberculosis facts and controversies","volume":"12","author":"P Baghaei","year":"2013","journal-title":"J Diabetes Metab Disord"},{"issue":"3","key":"pone.0345702.ref015","article-title":"Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB Control programme in South India","volume":"9","author":"BRV Velayutham","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"pone.0345702.ref016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147397","article-title":"Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review","volume":"11","author":"BE Thomas","year":"2016","journal-title":"PLoS One"},{"key":"pone.0345702.ref017","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment","author":"World Health Organization","year":"2025"},{"key":"pone.0345702.ref018","volume-title":"Discovering statistics using SPSS for windows: advanced techniques for the beginner","author":"AP Field","year":"2000"},{"key":"pone.0345702.ref019","article-title":"MDR tuberculosis in elderly","author":"A Bansal","year":"2022","journal-title":"Indian J Tuberc"},{"issue":"5","key":"pone.0345702.ref020","first-page":"1162","article-title":"Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes","volume":"111","author":"AL Kritski","year":"1997","journal-title":"Chest"},{"issue":"1","key":"pone.0345702.ref021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40249-016-0214-x","article-title":"Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies","volume":"6","author":"KT Kibret","year":"2017","journal-title":"Infect Dis Poverty"},{"key":"pone.0345702.ref022","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3389\/fimmu.2017.01316","article-title":"Malnutrition: modulator of immune responses in tuberculosis","volume":"8","author":"P Chandrasekaran","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0345702.ref023","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/ajcn\/75.4.720","article-title":"A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status","volume":"75","author":"E Karyadi","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"pone.0345702.ref024","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12879-018-3021-0","article-title":"Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China","volume":"18","author":"Q Liu","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0345702.ref025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.kint.2016.01.034","article-title":"Tuberculosis and chronic kidney disease: emerging global syndemic","volume":"90","author":"K Romanowski","year":"2016","journal-title":"Kidney Int"},{"issue":"4","key":"pone.0345702.ref026","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clnu.2023.01.016","article-title":"Tuberculosis and malnutrition: the European perspective","volume":"42","author":"J Ockenga","year":"2023","journal-title":"Clin Nutr"},{"issue":"7","key":"pone.0345702.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002595","article-title":"Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies","volume":"15","author":"N Alipanah","year":"2018","journal-title":"PLoS Med"},{"issue":"2","key":"pone.0345702.ref028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262318","article-title":"Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia","volume":"17","author":"MK Wakjira","year":"2022","journal-title":"PLoS One"},{"key":"pone.0345702.ref029","doi-asserted-by":"crossref","first-page":"100477","DOI":"10.1016\/j.jctube.2024.100477","article-title":"Malnutrition and unsuccessful tuberculosis treatment among people with multi-drug resistant tuberculosis in Uganda: a retrospective analysis","volume":"37","author":"S Engoru","year":"2024","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"5","key":"pone.0345702.ref030","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4269\/ajtmh.13-0011","article-title":"Weight gain and response to treatment for multidrug-resistant tuberculosis","volume":"89","author":"MT Gler","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"pone.0345702.ref031","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S2213-2600(15)00036-3","article-title":"Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies","volume":"3","author":"EV Kurbatova","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"6","key":"pone.0345702.ref032","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cmi.2023.02.013","article-title":"Long-term treatment outcomes in patients with multidrug-resistant tuberculosis","volume":"29","author":"C Maier","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"pone.0345702.ref033","unstructured":"World Health Organization, editor. Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions, 17-19 November 2020. Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions, 17-19 November 2020; 2021."},{"issue":"9","key":"pone.0345702.ref034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006914","article-title":"Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"4","author":"JC Johnston","year":"2009","journal-title":"PLoS One"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:27:38Z","timestamp":1775064458000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345702"}},"subtitle":[],"editor":[{"given":"Graeme","family":"Hoddinott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0345702","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}